SUNPHARMA posted a modest weekly return of 0.42%, outperforming its peers DRREDDY, DIVISLAB, and HINDUNILVR, which all saw negative returns. Despite its relatively low return, SUNPHARMA's Sharpe Ratio of 0.10 suggests that it generated some value for investors considering its volatility. Speaking of volatility, SUNPHARMA was quite risky this week, with a Max Drawdown of -1.16% and a volatility reading of 17.11%.

[Volatility: 17.11%]